KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Share-based Compensation (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Share-based Compensation for 11 consecutive years, with $5.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation fell 4.57% year-over-year to $5.6 million, compared with a TTM value of $34.8 million through Dec 2025, up 36.34%, and an annual FY2025 reading of $34.8 million, up 36.34% over the prior year.
  • Share-based Compensation was $5.6 million for Q4 2025 at Medpace Holdings, down from $6.3 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $16.9 million in Q1 2025 and bottomed at $2.9 million in Q1 2021.
  • Average Share-based Compensation over 5 years is $5.8 million, with a median of $5.3 million recorded in 2023.
  • The sharpest move saw Share-based Compensation tumbled 47.27% in 2021, then surged 291.93% in 2025.
  • Year by year, Share-based Compensation stood at $4.0 million in 2021, then skyrocketed by 40.49% to $5.6 million in 2022, then decreased by 7.65% to $5.2 million in 2023, then increased by 14.02% to $5.9 million in 2024, then decreased by 4.57% to $5.6 million in 2025.
  • Business Quant data shows Share-based Compensation for MEDP at $5.6 million in Q4 2025, $6.3 million in Q3 2025, and $6.0 million in Q2 2025.